NCT06436781View on ClinicalTrials.gov

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population

PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 12, 2024

Primary Completion Date

May 23, 2025

Study Completion Date

May 23, 2025

Conditions
Post Exercise InflammationExercise RecoveryMuscle FatigueMuscle Pain
Interventions
DRUG

Maolactin

Once daily dose of 2 capsules containing a total of 500mg/day Maolactin

DRUG

Maltodextrin

Once daily dose of 2 capsules of Maltodextrin containing a total of 0mg/day Maolactin

Trial Locations (1)

4006

RDC Clinical Pty Ltd, Brisbane

All Listed Sponsors
lead

RDC Clinical Pty Ltd

INDUSTRY

NCT06436781 - Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population | Biotech Hunter | Biotech Hunter